Lv52
1113 积分 2020-11-18 加入
αvβ3 CAR-T Cells Simultaneously Targeting Tumor and Metastases Produce Highly Effective Control in Preclinical Models of Melanoma and Triple-Negative Breast Cancer
45分钟前
已完结
Safety, Biodistribution, and Dosimetry of FAP and Integrin α v β 3 Dual-Targeting Radioligand 177 Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas
1天前
已完结
Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging
4天前
已完结
Integrin α v β 3 ‐targeted cancer therapy
5天前
已完结
Temperature‐induced structural change of integrin αvβ3 receptor and its interaction with the RGD peptide ligand
5天前
已完结
An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer
5天前
已完结
EGFR-targeting ADCs: From oncogene addiction to antigen-guided drug delivery
7天前
已完结
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
7天前
已完结
AGS62P1, a Novel Anti-FLT3 Antibody Drug Conjugate, Employing Site Specific Conjugation, Demonstrates Preclinical Anti-Tumor Efficacy in AML Tumor and Patient Derived Xenografts
13天前
已完结
皖公网安备34019202002308
